Clinical study of dexmedetomidine combined with transverse abdominis planar block in open gastrointestinal surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000028913

Enrollment

Unknown

Registered

2020-01-07

Start date

2020-01-06

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open gastrointestinal surgery

Interventions

the experimental group:transverse abdominis planar block combined with dexmedetomidine

the control group:dexmedetomidine

the blank group:no

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective open operation in gastrointestinal surgery: intestinal fistula, colorectal cancer, intestinal obstruction.

Exclusion criteria

Exclusion criteria: 1. obesity (body mass index > 35kg/m2); 2. know allergy to study drugs; 3. skin infection at the site of the needle puncture; 4. coagulopathy, and long-term use of opioids.

Design outcomes

Primary

Measure	Time frame
dosage of anesthetic intra-operation;	—

Secondary

Measure	Time frame
NRS score postoperation;complications;	—

Countries

China

Contacts

Public ContactYuanchao Gao

Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

murongling168@163.com+86 18310158399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026